In Brief This Week: GE Healthcare, Clarient; Expression Analysis, Illumina; LumiGene; Ontario Genomics Institute, ArcticDx; BASF Plant Sciences, Precision BioSciences | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has commenced its tender offer to acquire Clarient in a cash deal valued at approximately $570 million to $580 million. The firm announced the offer two weeks ago, and said today that the offer will expire at midnight New York City time on Dec. 6, unless extended.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.